Indoco Remedies Limited Total Liabilities
Indoco Remedies Limited total liabilities. Based on the latest financial reports, Indoco Remedies Limited (INDOCO) has total liabilities worth Rs-9.32 Billion INR (≈ $-100.80 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Indoco Remedies Limited's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Indoco Remedies Limited (2004–2026)
Total liabilities of Indoco Remedies Limited from 2004 to 2026. This chart illustrates how Indoco Remedies Limited's total liabilities have evolved over time, based on quarterly financial data. Explore Indoco Remedies Limited strategic investment ratio to see how much of total assets are deployed in long-term investments.
Indoco Remedies Limited Competitors by Total Liabilities
The table below lists competitors of Indoco Remedies Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Silver Storm Mining Ltd.
V:SVRS
|
Canada | CA$35.30 Million |
|
TRG Latin America Acquisitions Corp. Class A Ordinary Shares
NASDAQ:TRGS
|
USA | $12.50 Million |
|
Skue Sparebank
OL:SKUE
|
Norway | Nkr23.76 Billion |
|
Sweeten Real Estate Development Co Ltd
TW:5525
|
Taiwan | NT$15.03 Billion |
|
SES AI Corp
NYSE:SES
|
USA | $50.27 Million |
|
Jiangsu Boamax Technologies Group Co Ltd
SHE:002514
|
China | CN¥1.51 Billion |
|
Celik Halat ve Tel Sanayi AS
IS:CELHA
|
Turkey | TL1.70 Billion |
|
Bakkt Holdings Inc
NYSE:BKKT
|
USA | $42.50 Million |
Liability Composition Analysis (2004–2026)
This chart breaks down Indoco Remedies Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see INDOCO asset base.
Liquidity & Leverage Metrics
Indoco Remedies Limited Total Liabilities Ratios Explained
Indoco Remedies Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | N/A | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Indoco Remedies Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Indoco Remedies Limited (2004–2026)
The table below shows the annual total liabilities of Indoco Remedies Limited from 2004 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs16.61 Billion ≈ $179.65 Million |
+17.68% |
| 2025-03-31 | Rs14.12 Billion ≈ $152.65 Million |
+36.48% |
| 2024-03-31 | Rs10.34 Billion ≈ $111.85 Million |
+64.18% |
| 2023-03-31 | Rs6.30 Billion ≈ $68.13 Million |
+8.34% |
| 2022-03-31 | Rs5.81 Billion ≈ $62.88 Million |
+6.48% |
| 2021-03-31 | Rs5.46 Billion ≈ $59.06 Million |
-7.76% |
| 2020-03-31 | Rs5.92 Billion ≈ $64.03 Million |
-0.90% |
| 2019-03-31 | Rs5.97 Billion ≈ $64.61 Million |
+6.44% |
| 2018-03-31 | Rs5.61 Billion ≈ $60.70 Million |
+2.91% |
| 2017-03-31 | Rs5.45 Billion ≈ $58.98 Million |
+43.74% |
| 2016-03-31 | Rs3.79 Billion ≈ $41.03 Million |
+16.11% |
| 2015-03-31 | Rs3.27 Billion ≈ $35.34 Million |
+20.13% |
| 2014-03-31 | Rs2.72 Billion ≈ $29.42 Million |
-1.19% |
| 2013-03-31 | Rs2.75 Billion ≈ $29.77 Million |
+1.36% |
| 2012-03-31 | Rs2.72 Billion ≈ $29.37 Million |
+26.69% |
| 2011-03-31 | Rs2.14 Billion ≈ $23.18 Million |
+27.19% |
| 2010-03-31 | Rs1.69 Billion ≈ $18.23 Million |
+22.78% |
| 2009-03-31 | Rs1.37 Billion ≈ $14.85 Million |
+14.15% |
| 2008-03-31 | Rs1.20 Billion ≈ $13.01 Million |
+5.50% |
| 2007-03-31 | Rs1.14 Billion ≈ $12.33 Million |
+1.49% |
| 2006-03-31 | Rs1.12 Billion ≈ $12.15 Million |
+2.47% |
| 2005-03-31 | Rs1.10 Billion ≈ $11.85 Million |
+75.30% |
| 2004-03-31 | Rs625.25 Million ≈ $6.76 Million |
-- |
About Indoco Remedies Limited
Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides bra… Read more